Global News Hubb
Advertisement Banner
  • Home
  • Politics
  • Finance
  • Technology
  • Contact
No Result
View All Result
  • Home
  • Politics
  • Finance
  • Technology
  • Contact
No Result
View All Result
Wellnessnewshubb
No Result
View All Result
Home Politics

How will new Alzheimer’s drug lecanemab be prescribed?

admin by admin
December 6, 2022
in Politics


NEW YORK — A consensus may be emerging about how to prescribe the new Alzheimer’s drug lecanemab, according to remarks made by both a critic of other Alzheimer’s medicines and the CEO of the company that developed it.

Ivan Cheung, the CEO of Eisai, the lecanemab developer, said at a STAT event Monday night that if patients carry a particular genetic variant that increases the risk of bleeding in the brain when taking the drug, they should only take the medicine if they and their families are willing to submit to close monitoring from doctors.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED





Source link

Previous Post

South Indian Bank’s move on tier-2 bond won’t disrupt sector: Fitch

Next Post

Iran sentences five to death over killing of paramilitary member | Protests News

Next Post

Iran sentences five to death over killing of paramilitary member | Protests News

Recommended

Uruguay win over Ghana not enough to stay in Qatar — MercoPress

2 months ago

Iran sentences five to death over killing of paramilitary member | Protests News

2 months ago

© 2022 Global News Hubb All rights reserved.

Use of these names, logos, and brands does not imply endorsement unless specified. By using this site, you agree to the Privacy Policy and Terms & Conditions.

Navigate Site

  • Home
  • Politics
  • Finance
  • Technology
  • Contact

Newsletter Sign Up.

No Result
View All Result
  • Home
  • Politics
  • Finance
  • Technology
  • Contact

© 2022 Global News Hubb All rights reserved.